Page last updated: 2024-12-08

2,2'-bipyridine-3,3'-diol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,2'-bipyridine-3,3'-diol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID534031
SCHEMBL ID687180
MeSH IDM0512317

Synonyms (26)

Synonym
OPREA1_396035
2,2'-bipyridine-3,3'-diol, 98%
AKOS000814272
2,2'-bipyridine-3,3'-diol
36145-03-6
SCHEMBL687180
3,3'-dihydroxy-2,2'-bipyridine
2,2'-bipyridyl-3,3'-diol
[2,2'-bipyridine]-3,3'-diol
3,3'-dihydroxy-2,2'-bipyridyl
B4255
(2z)-2-(3-hydroxypyridin-2(1h)-ylidene)pyridin-3(2h)-one
DTXSID90583574
mfcd00075177
(2z)-2-(3-hydroxy-1h-pyridin-2-ylidene)pyridin-3-one
AS-58474
2-(3-hydroxypyridin-2-yl)pyridin-3-ol
3,3'-dihydroxybipyridyl
[2,2-bipyridine]-3,3-diol
[2,2'-bipyridyl]-3,3'-diol
T70828
YSWG799
A846174
SY055876
[2,2 inverted exclamation mark -bipyridine]-3,3 inverted exclamation mark -diol
CS-W016813
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's4 (57.14)24.3611
2020's1 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.02

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.02 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.02)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]